new semaglutide drugs Medicare launches weight loss drug option with $50 copay : NPR Retatrutide for weight loss: Study
Description
A total of 9340 participants with a high CV risk, who were 50 years of age, with HbA1c 7% were randomly assigned to receive placebo or liraglutide (1.8 mg)
A useful rule of thumb from clinicians is this: if a patient can reliably follow the tablet instructions every single morning, oral semaglutide can work well
Impact of weight loss on Health-Related Quality of Life
The starting dose is usually low and given once weekly
a gradual dose-escalation schedule is used in trials to minimise discomfort
